Leaflet accompanying the packaging: information for the patient
Warning! The leaflet should be kept. Information on the immediate packaging in a foreign language.
Progesterone Besins (Utrogestan 100 mg), 100 mg, soft capsules
Progesterone (micronized)
Progesterone Besins and Utrogestan 100 mg are different trade names for the same drug.
You should carefully read the contents of the leaflet before using the medicine, as it contains important information for the patient.
- You should keep this leaflet so that you can read it again if necessary.
- In case of any doubts, you should consult a doctor or pharmacist.
- This medicine has been prescribed for a specific person. It should not be given to others. The medicine may harm another person, even if the symptoms of their illness are the same.
- If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor, pharmacist, or nurse. See section 4.
Table of contents of the leaflet
- 1. What is Progesterone Besins and what is it used for
- 2. Important information before taking Progesterone Besins
- 3. How to take Progesterone Besins
- 4. Possible side effects
- 5. How to store Progesterone Besins
- 6. Contents of the packaging and other information
1. What is Progesterone Besins and what is it used for
What is Progesterone Besins
The medicine contains progesterone, which is a natural female sex hormone produced by the body. The action of this medicine is to regulate hormonal balance in the body. This medicine is a progestagen hormone therapy.
What is it used for
This medicine is used if the patient has disorders caused by a lack of progesterone in the body. The doctor will recommend taking this medicine in the following situations:
a) Progesterone deficiency
The level of progesterone produced by the ovaries (in the luteal phase) is below normal. In this situation, this medicine may be used to treat irregular periods.
b) Complete cessation of menstruation (menopause)
Supplementary treatment in hormone replacement therapy in women during menopause with a preserved uterus.
2. Important information before taking Progesterone Besins
When not to take Progesterone Besins:
- if the patient is allergic to progesterone or any of the other ingredients of this medicine (listed in section 6),
- if the patient has vaginal bleeding of unknown cause,
- if the patient has severe liver function disorders,
- if the patient has a liver tumor,
- if the patient has or is suspected of having breast or genital cancer,
- if the patient has active blood clots in a vein (thrombophlebitis), e.g. in the legs (deep vein thrombophlebitis) or lungs (pulmonary embolism), or if the patient has had such blood clots in the past,
- if the patient has bleeding into the brain,
- if the patient has a rare blood disease called "porphyria", which is inherited.
- In the case of taking Progesterone Besins during menopause in combination with another hormonal treatment, so-called "estrogen", you should also check the information leaflet of that medicine (estrogen) to see when not to take it.
Warnings and precautions
Before starting to take Progesterone Besins, you should discuss it with your doctor.
- This medicine, when used as recommended, does not have a contraceptive effect.
- Before starting hormone replacement therapy during menopause (and later at regular annual intervals), you should consult a doctor who will perform a breast and pelvic examination.
- If treatment with Progesterone Besins is started too early in the month, especially before the 15th day of the cycle, the cycle may be shortened or bleeding may occur.
You should tell your doctor if:
- you have had blood clots in your veins (venous thrombosis) in the past,
- you have uterine bleeding.
You should stop taking this medicine if:
- you experience any vision disorders (e.g. vision loss, double vision, pathological changes in the blood vessels of the retina),
- you have blood clots (thromboembolic disease) or thrombosis,
- you have severe headaches.
If the patient experiences a lack of menstruation during treatment, they should make sure they are not pregnant.
During treatment, the uterine lining may start to grow excessively (endometrial hyperplasia) or this growth may worsen.
If, during prolonged treatment, at the end of treatment, or after stopping treatment, unexpected bleeding or spotting occurs, which persists, you should consult a doctor.
Children
The efficacy and safety of Progesterone Besins in children have not been established.
Progesterone Besins and other medicines
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
Some medicines may affect the action of Progesterone Besins:
- barbiturates, used in the past for sleep disorders or to treat anxiety,
- medicines used for epilepsy (phenytoin, carbamazepine),
- certain antibiotics (ampicillin, tetracyclines, rifampicin),
- phenylbutazone (an anti-inflammatory medicine),
- spironolactone (a diuretic),
- certain antifungal medicines (ketoconazole, griseofulvin).
Similarly, Progesterone Besins may affect the action of certain medicines used to treat diabetes.
Herbal products containing St. John's Wort ( Hypericum perforatum) may weaken the action of Progesterone Besins.
Taking Progesterone Besins with food and drink
The medicine should be taken regardless of meals, preferably in the evening before bedtime.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking this medicine.
Pregnancy
If you are pregnant, think you may be pregnant, or plan to become pregnant, you should consult your doctor before taking this medicine or any other medicine.
Breastfeeding
Women who are breastfeeding should not take this medicine.
Before starting to take this medicine, you should discuss it with your doctor or pharmacist.
Fertility
This medicine may be taken by women who have problems getting pregnant. Therefore, this medicine does not have any harmful effect on fertility.
Before starting to take this medicine, you should discuss it with your doctor or pharmacist.
Driving and using machines
You should not drive or operate machines if you experience drowsiness or dizziness.
Progesterone Besins contains soya lecithin
The medicine contains soya lecithin (soybean oil). Do not take if you are hypersensitive to peanuts or soya.
3. How to take Progesterone Besins
This medicine should always be taken as recommended by your doctor. If you have any doubts, you should consult your doctor or pharmacist.
Recommended dose for irregular menstrual bleeding
- The medicine should be taken for 10 days in the cycle, usually from the 17th to the 26th day inclusive.
- The dose usually ranges from 200 to 300 mg of progesterone per day, taken in 1 or 2 divided doses, i.e. 200 mg in the evening before bedtime and 100 mg the next morning, if necessary.
Recommended dose for menopause treatment
- In women during menopause with a preserved uterus, it is not recommended to take estrogen alone without combination with another treatment.
- Treatment should be supplemented with progesterone taken in a single dose of 200 mg before bedtime for at least 12 to 14 days a month (during the last 2 weeks of each treatment sequence).
- Then, for about a week without replacement therapy, during which time withdrawal bleeding may occur.
How to take the capsules
The capsules should be swallowed, washed down with a small amount of water.
The capsules should not be taken with food.
This medicine is best taken in the evening before bedtime. The second dose should be taken the next morning.
Taking a higher dose of Progesterone Besins than recommended
You should consult your doctor or pharmacist immediately.
Overdose symptoms may occur, which include dizziness, fatigue, intense feeling of well-being, or painful periods. In such a case, the dose can be reduced. You should always consult your doctor first.
Missing a dose of Progesterone Besins
A missed dose of the medicine should be taken as soon as you remember. However, if it is almost time for the next dose, you should skip the missed dose.
You should not take a double dose to make up for a missed dose.
Stopping treatment with Progesterone Besins
Your doctor will tell you how long to take this medicine. You should not stop treatment prematurely.
If you have any further doubts about taking this medicine, you should consult your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You should stop taking this medicine immediately if you experience:
- stroke, blood clots, or internal bleeding into the brain,
- blood clots in the veins of the legs or pelvis,
- sudden severe headache,
- vision disorders,
- yellowing of the skin or whites of the eyes (jaundice).
The following side effects are common (occurring in less than 1 in 10 patients):
- headaches,
- changes in menstrual cycle or bleeding at a different time than withdrawal bleeding. In such a case, your doctor may change the way you take the medicine.
The following side effects are uncommon (occurring in less than 1 in 100 patients):
- changes in the breasts, breasts may become tender,
- feeling of fatigue or dizziness,
- nausea (vomiting), diarrhea, constipation,
- yellowing of the skin or whites of the eyes (jaundice),
- itching of the skin, acne.
The following side effects are rare (occurring in less than 1 in 1000 patients):
- allergic reactions,
- nausea.
The following side effects are very rare (occurring in less than 1 in 10,000 patients):
- depression,
- rash (which may be itchy),
- darkening or discoloration of the skin (chloasma, pregnancy mask).
Additional side effects reported in connection with hormone replacement therapy containing estrogen and progestagen:
- estrogen-dependent benign or malignant tumor, e.g. endometrial cancer,
- blood clots in the veins (venous thromboembolic disease) due to the occurrence of blood clots (thrombosis) in the deep veins of the legs or pelvis, as well as pulmonary embolism, which occur more frequently in women taking hormone replacement therapy than in women who do not take it,
- heart attack (myocardial infarction) and stroke,
- gallbladder disorders,
- brown discoloration of the skin (chloasma), various skin disorders with blistering and nodules (erythema multiforme, nodular erythema, vascular purpura),
- possibly dementia.
If the treatment sequence is started too early in the month (especially before the 15th day of the cycle)
15. day of the cycle)
The cycle may be shortened and bleeding may occur at a different time than withdrawal bleeding.
Reporting side effects
If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel. +48 22 49 21 301, fax + 48 22 49 21 309, website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of this medicine.
5. How to store Progesterone Besins
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Store in a temperature below 30°C. Do not store in the refrigerator. Store in the original packaging to protect from light.
Do not use this medicine if you notice any visible signs of deterioration. The medicine should be returned to the pharmacist.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
6. Contents of the packaging and other information
What Progesterone Besins contains
- The active substance of the medicine is micronized progesterone. One capsule contains 100 mg of progesterone in a soft capsule.
- The other ingredients are: soya lecithin, purified sunflower oil, coating: titanium dioxide (E 171), gelatin, glycerol, purified water.
What Progesterone Besins looks like and what the packaging contains
- Progesterone Besins, 100 mg is available in packs of 30 or 90 soft capsules, intended for oral use and packaged in blisters and cardboard boxes.
- Progesterone Besins, 100 mg are round, slightly yellow soft capsules, containing a white suspension.
For more detailed information, you should contact the marketing authorization holder or parallel importer.
Marketing authorization holder in the Netherlands, the country of export:
Besins Healthcare Netherlands B.V.
Servaasbolwerk 14
3512NK Utrecht
Netherlands
Manufacturer:
Cyndea Pharma S.L.
Polígono Industrial Emiliano Revilla Sanz
Avenida de Ágreda 31
Olvega 42110 (Soria), Spain
Parallel importer:
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Repackaged by:
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Netherlands marketing authorization number: RVG 11473
Parallel import authorization number: 40/25
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Date of approval of the leaflet: 29.01.2025
[Information about the trademark]
Belgium | Progestérone BESINS 100 mg, capsule molles |
Luxembourg | Progestérone BESINS 100 mg, capsule molles |
Netherlands | Progesteron Besins 100 mg zacht capsules |
Poland | Progesterone Besins, 100 mg, kapsułki, miękkie |
Germany | Utrogest 100 mg Weichkapseln |